title: Nanochemoprevention by encapsulation of (-)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability.
abstract: Nanochemoprevention by oral consumption was developed by the encapsulation of (-)-epigallocatechin-3-gallate (EGCG) with nanoparticles that were electrostatically assembled from bioactive caseinophosphopeptides and chitosan, which was highly biocompatible and able to enhance the bioavailability of EGCG.
authors.affiliation: College of Food Science and Technology, Nanjing Agricultural University, Nanjing 210095, People's Republic of China.
authors.forename: Bing
authors.initials: B
authors.lastname: Hu
authors.forename: Yuwen
authors.initials: Y
authors.lastname: Ting
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Yang
authors.forename: Wenping
authors.initials: W
authors.lastname: Tang
authors.forename: Xiaoxiong
authors.initials: X
authors.lastname: Zeng
authors.forename: Qingrong
authors.initials: Q
authors.lastname: Huang
mesh_terms: D001682:Biological Availability; D018938:Caco-2 Cells; D002214:Capsules; D002392:Catechin / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics; D018890:Chemoprevention; D048271:Chitosan / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry*; D006801:Humans; D053758:Nanoparticles / Q000737:chemistry*; D010446:Peptide Fragments / Q000737:chemistry*
chemical_list: D002214:Capsules; D004337:Drug Carriers; D010446:Peptide Fragments; D002392:Catechin; D048271:Chitosan; C045651:epigallocatechin gallate